213 related articles for article (PubMed ID: 20472364)
1. Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation.
Vicini F; Beitsch P; Quiet C; Gittleman M; Zannis V; Fine R; Whitworth P; Kuerer H; Haffty B; Keisch M; Lyden M
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):808-17. PubMed ID: 20472364
[TBL] [Abstract][Full Text] [Related]
2. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience.
Chao KK; Vicini FA; Wallace M; Mitchell C; Chen P; Ghilezan M; Gilbert S; Kunzman J; Benitez P; Martinez A
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):32-40. PubMed ID: 17467920
[TBL] [Abstract][Full Text] [Related]
3. Ductal carcinoma in situ treated with breast-conserving surgery and accelerated partial breast irradiation: comparison of the Mammosite registry trial with intergroup study E5194.
Goyal S; Vicini F; Beitsch PD; Kuerer H; Keisch M; Motwani S; Jeruss JS; Lyden M; Haffty BG
Cancer; 2011 Mar; 117(6):1149-55. PubMed ID: 21381007
[TBL] [Abstract][Full Text] [Related]
4. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI).
Vicini F; Beitsch PD; Quiet CA; Keleher AJ; Garcia D; Snider HC; Gittleman MA; Zannis VJ; Kuerer HM; Lyden M
Cancer; 2008 Feb; 112(4):758-66. PubMed ID: 18181095
[TBL] [Abstract][Full Text] [Related]
5. Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite clinical trial for ductal carcinoma-in-situ of the breast.
Jeruss JS; Vicini FA; Beitsch PD; Haffty BG; Quiet CA; Zannis VJ; Keleher AJ; Garcia DM; Snider HC; Gittleman MA; Whitacre E; Whitworth PW; Fine RE; Arrambide S; Kuerer HM
Ann Surg Oncol; 2006 Jul; 13(7):967-76. PubMed ID: 16788759
[TBL] [Abstract][Full Text] [Related]
6. Local control, toxicity, and cosmesis in women younger than 50 enrolled onto the American Society of Breast Surgeons MammoSite Radiation Therapy System registry trial.
Khan AJ; Vicini F; Beitsch P; Haffty B; Quiet C; Keleher A; Garcia D; Snider H; Gittleman M; Zannis V; Kuerer H; Whitacre E; Whitworth P; Fine R
Ann Surg Oncol; 2009 Jun; 16(6):1612-8. PubMed ID: 19319606
[TBL] [Abstract][Full Text] [Related]
7. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
[TBL] [Abstract][Full Text] [Related]
8. Descriptions and outcomes of insertion techniques of a breast brachytherapy balloon catheter in 1403 patients enrolled in the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial.
Zannis V; Beitsch P; Vicini F; Quiet C; Keleher A; Garcia D; Snider H; Gittleman M; Kuerer H; Whitacre E; Whitworth P; Fine R; Haffty B; Stolier A; Mabie J
Am J Surg; 2005 Oct; 190(4):530-8. PubMed ID: 16164915
[TBL] [Abstract][Full Text] [Related]
9. Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience.
Harper JL; Jenrette JM; Vanek KN; Aguero EG; Gillanders WE
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):169-74. PubMed ID: 15629608
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with optimal cosmetic results at 36 months in patients treated with accelerated partial breast irradiation (APBI) on the American Society of Breast Surgeons (ASBrS) MammoSite Breast Brachytherapy Registry Trial.
Goyal S; Khan AJ; Vicini F; Beitsch PD; Lyden M; Keisch M; Haffty BG
Ann Surg Oncol; 2009 Sep; 16(9):2450-8. PubMed ID: 19517191
[TBL] [Abstract][Full Text] [Related]
11. First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial.
Vicini FA; Beitsch PD; Quiet CA; Keleher A; Garcia D; Snider HC; Gittleman MA; Zannis VJ; Kuerer H; Whitacre EB; Whitworth PW; Fine RE; Haffty BG; Arrambide LS
Cancer; 2005 Sep; 104(6):1138-48. PubMed ID: 16088962
[TBL] [Abstract][Full Text] [Related]
12. Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite(®) breast brachytherapy registry trial.
Shah C; Badiyan S; Ben Wilkinson J; Vicini F; Beitsch P; Keisch M; Arthur D; Lyden M
Ann Surg Oncol; 2013 Oct; 20(10):3279-85. PubMed ID: 23975302
[TBL] [Abstract][Full Text] [Related]
13. Outcomes after accelerated partial breast irradiation in patients with ASTRO consensus statement cautionary features.
McHaffie DR; Patel RR; Adkison JB; Das RK; Geye HM; Cannon GM
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):46-51. PubMed ID: 20732760
[TBL] [Abstract][Full Text] [Related]
14. Four-year clinical update from the American Society of Breast Surgeons MammoSite brachytherapy trial.
Nelson JC; Beitsch PD; Vicini FA; Quiet CA; Garcia D; Snider HC; Gittleman MA; Zannis VJ; Whitworth PW; Fine RE; Keleher AJ; Kuerer HM
Am J Surg; 2009 Jul; 198(1):83-91. PubMed ID: 19268900
[TBL] [Abstract][Full Text] [Related]
15. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with optimal long-term cosmetic results in patients treated with accelerated partial breast irradiation using balloon-based brachytherapy.
Vicini FA; Keisch M; Shah C; Goyal S; Khan AJ; Beitsch PD; Lyden M; Haffty BG
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):512-8. PubMed ID: 22079730
[TBL] [Abstract][Full Text] [Related]
17. Accelerated partial breast irradiation: 5-year results of the German-Austrian multicenter phase II trial using interstitial multicatheter brachytherapy alone after breast-conserving surgery.
Strnad V; Hildebrandt G; Pötter R; Hammer J; Hindemith M; Resch A; Spiegl K; Lotter M; Uter W; Bani M; Kortmann RD; Beckmann MW; Fietkau R; Ott OJ
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):17-24. PubMed ID: 20605365
[TBL] [Abstract][Full Text] [Related]
18. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
[TBL] [Abstract][Full Text] [Related]
19. Limitations of the American Society of Therapeutic Radiology and Oncology Consensus Panel guidelines on the use of accelerated partial breast irradiation.
Vicini F; Arthur D; Wazer D; Chen P; Mitchell C; Wallace M; Kestin L; Ye H
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):977-84. PubMed ID: 20510540
[TBL] [Abstract][Full Text] [Related]
20. Phase I/II study evaluating early tolerance in breast cancer patients undergoing accelerated partial breast irradiation treated with the mammosite balloon breast brachytherapy catheter using a 2-day dose schedule.
Wallace M; Martinez A; Mitchell C; Chen PY; Ghilezan M; Benitez P; Brown E; Vicini F
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):531-6. PubMed ID: 19775830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
